Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pimpinelli

Showing results (391-400 of 542) with videos related to

Pageof 55
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2019
The Hsp70 chaperone is a major player in stress-induced transposable element activationUgo Cappucci, Fabrizia Noro, Assunta Maria Casale, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 6, 2014
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution studyF Marchesi, F Pimpinelli, M L Dessanti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 25, 2018
Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphomaA Pileri, C Agostinelli, F Fuligni, et al.
Frontiers in Medicine|September 23, 2022
Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologicsDario Graceffa, Francesca Sperati, Claudio Bonifati, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 20, 2015
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cellsAnna Laurenzana, Alessio Biagioni, Francesca Bianchini, et al.
Expert Opinion on Biological Therapy|February 29, 2024
Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspectiveGabriele Roccuzzo, Eleonora Gherardi, Michele Maio, et al.
European Journal of Haematology|February 14, 2009
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapiesStefano Pulini, Serena Rupoli, Gaia Goteri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 5, 2014
Management of local skin reactions after the application of ingenol mebutate gel for the treatment of actinic keratosis: four illustrative casesC Longo, L Neri, G Argenziano, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2022
Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, et al.
Journal of the American Academy of Dermatology|December 12, 2018
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian centerVieri Grandi, Roberto Maglie, Emiliano Antiga, et al.
Pageof 55

Showing results (391-400 of 542) with videos related to

Sort By:
Pageof 55
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2019
The Hsp70 chaperone is a major player in stress-induced transposable element activationUgo Cappucci, Fabrizia Noro, Assunta Maria Casale, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 6, 2014
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution studyF Marchesi, F Pimpinelli, M L Dessanti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 25, 2018
Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphomaA Pileri, C Agostinelli, F Fuligni, et al.
Frontiers in Medicine|September 23, 2022
Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologicsDario Graceffa, Francesca Sperati, Claudio Bonifati, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 20, 2015
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cellsAnna Laurenzana, Alessio Biagioni, Francesca Bianchini, et al.
Expert Opinion on Biological Therapy|February 29, 2024
Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspectiveGabriele Roccuzzo, Eleonora Gherardi, Michele Maio, et al.
European Journal of Haematology|February 14, 2009
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapiesStefano Pulini, Serena Rupoli, Gaia Goteri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 5, 2014
Management of local skin reactions after the application of ingenol mebutate gel for the treatment of actinic keratosis: four illustrative casesC Longo, L Neri, G Argenziano, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2022
Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, et al.
Journal of the American Academy of Dermatology|December 12, 2018
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian centerVieri Grandi, Roberto Maglie, Emiliano Antiga, et al.
Pageof 55